| abstract |
Provided are novel nitrosated and / or nitrosylated nebivolol and the like for treating cardiovascular diseases. Nitrosated and / or nitrosylated nebivolol metabolites, and at least one nitrosated and / or nitrosylated nebivolol and / or at least one nitrosated and / or nitrosylated nebivolol metabolite, and at least one nitric oxide A novel composition comprising a donor and / or at least one antioxidant or a pharmaceutically acceptable salt thereof, and / or at least one nitrosated compound used to treat cardiovascular disease, Nebivolol and / or at least one nebivolol metabolite and at least one nitric oxide donor, and at least one antioxidant or a pharmaceutically acceptable salt thereof. [Selection] Figure 1 |